Conditions: Macular Degeneration
Keywords: Long-Term Study For Pegaptanib Sodium In Patients With Subfoveal Choroidal Neovascularization Secondary To Age-Related Macular Degeneration
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 61
Healthy volunteers: no

Brief summary:
This study will examine the safety and efficacy of pegaptanib sodium in Japanese patients with wet-type age-related macular degeneration (AMD), who benefit further treatment and who want to continue the treatment after completion of the preceding study (A5751010).

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: pegaptanib sodium
Intervention descriptions: intervention 1: 1 drop per dosed eye per protocol.

Protocol document: